[Uncoupling protein-3 in skeletal muscle].
Mori
Yutaka
Y
Department of Internal Medicine, National Higashi-Utsunomiya Hospital.
D000818:Animals; D001629:Bezafibrate / Q000494:pharmacology / Q000627:therapeutic use; D002352:Carrier Proteins / Q000378:metabolism / Q000502:physiology; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000209:etiology; D004734:Energy Metabolism / Q000187:drug effects; D005947:Glucose / Q000378:metabolism; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D007333:Insulin Resistance; D007473:Ion Channels; D050356:Lipid Metabolism; D024101:Mitochondrial Proteins; D018482:Muscle, Skeletal / Q000378:metabolism*; D009765:Obesity / Q000188:drug therapy / Q000209:etiology; D000071247:Uncoupling Protein 3
D002352:Carrier Proteins; D000960:Hypolipidemic Agents; D007473:Ion Channels; D024101:Mitochondrial Proteins; C000604392:UCP3 protein, human; D000071247:Uncoupling Protein 3; D005947:Glucose; D001629:Bezafibrate